In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Expected publication date

Area of interest

Type

Guidance programme

Showing 281 to 285 of 285

TitleTypeExpected publication date
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments ID6388Technology appraisal guidanceTBC
Zanubrutinib for treating relapsed or refractory mantle cell lymphoma after 1 or more treatments [ID6392]Technology appraisal guidance
Zanubrutinib for untreated chronic lymphocytic leukaemia [ID5079]Technology appraisal guidanceTBC
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]Technology appraisal guidanceTBC
Zuranolone for treating postnatal depression [ID6431]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All